The PE Ratio as of December 2024 (TTM) for Acorda Therapeutics, Inc. (ACOR) is -0.00

According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -98.84% compared to the average of -0.28 of the last 4 quarters.

Acorda Therapeutics, Inc. (ACOR) Historical PE Ratio (quarterly & annually)

How has ACOR PE Ratio performed in the past?

The mean historical PE Ratio of Acorda Therapeutics, Inc. over the last ten years is 25.76. The current -0.00 PE Ratio has changed -101.26% with respect to the historical average. Over the past ten years (40 quarters), ACOR's PE Ratio was at its highest in in the December 2014 quarter at 1.28K. The PE Ratio was at its lowest in in the March 2016 quarter at -569.88.

Acorda Therapeutics, Inc. (ACOR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Acorda Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acorda Therapeutics, Inc. (ACOR) Average PE Ratio

How has ACOR PE Ratio performed in the past?

The current PE Ratio of Acorda Therapeutics, Inc. (ACOR) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Acorda Therapeutics, Inc. (ACOR) PE Ratio vs. Peers

How is ACOR’s PE Ratio compared to its peers?

Acorda Therapeutics, Inc.’s PE Ratio is less than Taisho Pharmaceutical Holdings Co., Ltd. (68.13), less than Shionogi & Co., Ltd. (12.17), greater than Vivesto AB (-0.37), greater than Pacira BioSciences, Inc. (-9.79), greater than Sunshine Biopharma, Inc. (-0.96), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Biofrontera Inc. (-0.44), greater than Jupiter Wellness, Inc. (-1.02), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.21), less than Lifecore Biomedical, Inc. (35.28), greater than Journey Medical Corporation (-5.12), greater than Akanda Corp. (-0.04), greater than China Pharma Holdings, Inc. (-0.66), greater than Universe Pharmaceuticals INC (-0.12), greater than Sonoma Pharmaceuticals, Inc. (-0.75), greater than Petros Pharmaceuticals, Inc. (-0.27), greater than Evoke Pharma, Inc. (-1.14), greater than Cumberland Pharmaceuticals Inc. (-3.25), greater than Agile Therapeutics, Inc. (-0.65), greater than PainReform Ltd. (-0.90),

Build a custom stock screener for Acorda Therapeutics, Inc. (ACOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acorda Therapeutics, Inc. (ACOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.